RxDoctor Payments Data

Todd Decker, MD

Family Medicine · Petoskey, MINPI 1871600676

Payments from drug & device makers

$1,094in general payments, 2019–2025

Across 63 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$388
  • AbbVie$194
  • Novo Nordisk$93
  • GSK$63
  • Pfizer$60
  • Lilly USA, LLC$52
  • plus $244 from 11 others

What the payments were for

  • Food & beverage$1,094100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,094 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$149,910
Medicare patients
286
Services billed
2,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban140$123,014
JardianceEmpagliflozin80$74,990
OzempicSemaglutide58$60,538
TrulicityDulaglutide31$46,007
XareltoRivaroxaban23$28,759
MyrbetriqMirabegron34$25,717
FarxigaDapagliflozin Propanediol28$25,064
Bydureon BciseExenatide Microspheres15$20,376
Repatha SureclickEvolocumab26$18,427
InvokanaCanagliflozin16$18,273
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$16,595
CreonLipase/Protease/Amylase12$13,281
EntrestoSacubitril/Valsartan12$9,251
JanuviaSitagliptin Phosphate14$8,416
SymbicortBudesonide/Formoterol Fumarate33$7,208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$60$123,014140 claims
Boehringer IngelheimJardiance, Spiriva Respimat$29$80,57991 claims
Novo NordiskOzempic$93$60,53858 claims
Lilly USA, LLCTrulicity$52$46,00731 claims
AstraZenecaFarxiga, Symbicort$36$32,27261 claims
Astellas Pharma US IncMyrbetriq$45$25,71734 claims
AbbVieCreon, Linzess$194$19,50024 claims
GSKTrelegy Ellipta$63$16,59511 claims
NovartisEntresto$25$9,25112 claims
MerckJanuvia$17$8,41614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Petoskey

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →